| Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers AJV Thompson, T Nguyen, D Iser, A Ayres, K Jackson, M Littlejohn, ... Hepatology 51 (6), 1933-1944, 2010 | 535 | 2010 |
| Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein K Visvanathan, NA Skinner, AJV Thompson, SM Riordan, V Sozzi, ... Hepatology 45 (1), 102-110, 2007 | 451 | 2007 |
| The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway T Lang, C Lo, N Skinner, S Locarnini, K Visvanathan, A Mansell Journal of hepatology 55 (4), 762-769, 2011 | 241 | 2011 |
| The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection EJ Gane, YS Lim, SC Gordon, K Visvanathan, E Sicard, RN Fedorak, ... Journal of hepatology 63 (2), 320-328, 2015 | 238 | 2015 |
| Peripheral Blood Mononuclear Cell Expression of Toll–Like Receptors and Relation to Cytokine Levels in Cirrhosis SM Riordan, N Skinner, A Nagree, H McCallum, CJ McIver, J Kurtovic, ... Hepatology 37 (5), 1154-1164, 2003 | 228 | 2003 |
| Epidemiology of sepsis in Victoria, Australia V Sundararajan, CM MacIsaac, JJ Presneill, JF Cade, K Visvanathan Critical care medicine 33 (1), 71-80, 2005 | 214 | 2005 |
| Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens NA Skinner, CM MacIsaac, JA Hamilton, K Visvanathan Clinical & Experimental Immunology 141 (2), 270-278, 2005 | 175 | 2005 |
| Toll‐like receptors and their role in gastrointestinal disease AG Testro, K Visvanathan Journal of gastroenterology and hepatology 24 (6), 943-954, 2009 | 158 | 2009 |
| Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B M Giles, K Visvanathan, S Lewin, S Bowden, S Locarnini, T Spelman, ... Gut 64 (11), 1810-1815, 2015 | 132 | 2015 |
| An overview of the innate and adaptive immune system in inflammatory bowel disease MC Choy, K Visvanathan, P De Cruz Inflammatory bowel diseases 23 (1), 2-13, 2017 | 129 | 2017 |
| Vitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study S Ojaimi, NA Skinner, BJG Strauss, V Sundararajan, I Woolley, ... Journal of translational medicine 11, 1-7, 2013 | 111 | 2013 |
| Essential clinical immunology JB Zabriskie Cambridge University Press, 2009 | 110 | 2009 |
| Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury SM Riordan, NA Skinner, J Kurtovic, S Locarnini, CJ McIver, R Williams, ... Inflammation research 55, 279-285, 2006 | 108 | 2006 |
| Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)–coinfected individuals after the initiation of HBV-active antiretroviral therapy M Crane, B Oliver, G Matthews, A Avihingsanon, S Ubolyam, V Markovska, ... The Journal of infectious diseases 199 (7), 974-981, 2009 | 106 | 2009 |
| Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial MF Yuen, K Agarwal, EJ Gane, C Schwabe, SH Ahn, DJ Kim, YS Lim, ... The lancet Gastroenterology & hepatology 5 (2), 152-166, 2020 | 102 | 2020 |
| Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders K Visvanathan, G Dusheiko, M Giles, ML Wong, N Phung, S Walker, S Le, ... Gut 65 (2), 340-350, 2016 | 102 | 2016 |
| Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B SM Riordan, N Skinner, J Kurtovic, S Locarnini, K Visvanathan Clinical and Vaccine Immunology 13 (8), 972-974, 2006 | 99 | 2006 |
| Characterization of the innate immune signalling pathways in hepatocyte cell lines S Preiss, A Thompson, X Chen, S Rodgers, V Markovska, P Desmond, ... Journal of viral hepatitis 15 (12), 888-900, 2008 | 98 | 2008 |
| Inhibition of bacterial superantigens by peptides and antibodies K Visvanathan, A Charles, J Bannan, P Pugach, K Kashfi, JB Zabriskie Infection and immunity 69 (2), 875-884, 2001 | 93 | 2001 |
| What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium DL Horn, DC Morrison, SM Opal, R Silverstein, K Visvanathan, ... Clinical infectious diseases 31 (4), 851-858, 2000 | 91 | 2000 |
Alexander J ThompsonProfessor of Gastroenterology, St Vincent's Hospital, University of MelbourneVerificeret mail på svhm.org.au
